
Keywords: کل PSA; prostate-specific antigen; prostatic neoplasms; transplantation; graft survival; cPSA; complexed PSA; ESLD; end stage liver disease; ESRD; end stage renal disease; fPSA; free PSA; HD; hemodialysis; MMF; mycophenolate mofetil; PSA; prostate specific antige